Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
02/2001
02/20/2001CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof
02/20/2001CA2005283C Radiation-sensitive, ethylenically unsaturated, copolymerizable compounds and their preparation
02/15/2001WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001WO2001010835A1 Antibacterial agents
02/15/2001WO2001010834A2 Antibacterial agents
02/15/2001WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives
02/15/2001WO2001010825A1 Carbamate derivatives and agricultural/horticultural bactericides
02/15/2001WO2001010823A1 Carboxylic acid amides, their production and their use as drugs
02/15/2001WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
02/15/2001WO2001010433A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
02/15/2001WO2000054759A3 Lxr modulators
02/15/2001DE19937496A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents, e.g. for treating viral infections, tumors, inflammation or autoimmune disease
02/15/2001CA2382759A1 Agent for the remedy of neural damage having a nitrogen-containing compound as the active ingredient
02/15/2001CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof
02/15/2001CA2378310A1 Arylsulfonamido-substituted hydroxamic acid derivatives
02/14/2001EP1075469A1 Piperazine derivatives and process for the preparation thereof
02/14/2001CN1284060A Novel metalloproteinase inhibitors
02/14/2001CN1284059A Biphenylamidine derivatives
02/14/2001CN1284057A Adamantane derivatives
02/13/2001US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent
02/13/2001US6187918 Catalysts for asymmetric addition of organozinc reagents to aldehydes and method for preparation
02/13/2001CA2147808C Acetylenic biaromatic compounds containing an adamantyl group; pharmaceutical and cosmetic compositions containing them and uses thereof
02/13/2001CA2147806C Polyenic compounds; pharmaceutical and cosmetic compositions containing them and uses
02/13/2001CA2006114C Low volatility salts
02/08/2001WO2001009169A2 Cysteine protease inhibitors
02/08/2001WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
02/08/2001WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors
02/08/2001WO2001009091A1 Method for producing protected acyl guanidines by way of mukaiyama reaction
02/08/2001WO2001009083A1 Production of n-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamides
02/08/2001WO2001009079A1 2-alkyl-5-halogen-pent-4-ene carboxylic acids and their production
02/08/2001WO2001009037A1 Zeolite ssz-52
02/08/2001WO2001008672A2 Glucamine compounds for treating hepatitis virus infections
02/08/2001WO2000066528A3 Quinones for treatment of diseases
02/08/2001WO2000059851A8 Derivatives of venlafaxine and methods of preparing and using the same
02/08/2001WO2000058295A3 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
02/08/2001DE19937494A1 New carboxylic acid amides are Factor Xa and serine protease inhibitors, useful for the treatment and prevention of thrombotic disorders, tumors and fibrin-dependent inflammation
02/08/2001CA2380578A1 Ring opened cpis
02/08/2001CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
02/08/2001CA2362785A1 Glucamine compounds for treating hepatitis virus infections
02/07/2001EP1073641A2 New substituted amides, their production and their use
02/07/2001EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2
02/07/2001EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
02/07/2001EP1073624A1 Aminomethyl-benzoic ester derivatives as tryptase inhibitors
02/07/2001EP0862624A4 Water soluble cross-linking agents
02/07/2001EP0538422B1 New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders
02/07/2001CN1283195A 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype ligands
02/07/2001CN1283181A Substituted beta-alanines
02/07/2001CN1282740A Intermediate compound for preparing xibo ketone
02/07/2001CN1061648C Antiarrhythmic and cardioprotective substituted indenoyiguanidines
02/06/2001US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites
02/06/2001US6184224 Drug resistance and side effect reduction
02/06/2001US6183665 Granular N-alkyl ammonium acetonitrile compositions
02/01/2001WO2001007435A2 N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands
02/01/2001WO2001007427A1 Vesamicol piperazine derivatives and drugs containing the same
02/01/2001WO2001007403A1 Naphthyl-substituted sulfonamides
02/01/2001WO2001007402A1 Antiviral agents
02/01/2001WO2001007029A2 Substituted guanidines and the use thereof
02/01/2001WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
02/01/2001DE19935693A1 Verfahren zur Herstellung geschützter Acylguanidine durch Mukaiyama Reaktion Process for the preparation of protected acylguanidines by Mukaiyama reaction
02/01/2001DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production
01/2001
01/31/2001EP1072591A1 Novel urea derivatives
01/31/2001EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient
01/31/2001EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application
01/31/2001EP1071660A1 N-sulphonyl and n-sulphinyl phenylglycinamide
01/31/2001EP1071656A1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same
01/31/2001EP1036070A4 N-alkyl ammonium acetonitrile salts, methods therefor and compositions therewith
01/31/2001CN1282326A Anilide derivative, production and use thereof
01/31/2001CN1282319A Aminobutanoic acid derivatives
01/31/2001CN1061339C Novel sulfonamide inhibitors of aspartyl protease
01/30/2001USRE37035 Phenylacetic acid benzylamides
01/30/2001US6180787 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides
01/30/2001US6180633 Drug resistance and multidrug resistance modulators
01/30/2001US6180623 Used as analgesics and anti-pruritic agents
01/30/2001US6180113 Used in tumor therapy and interventional radiology
01/25/2001WO2001005763A2 Compounds with activity on muscarinic receptors
01/25/2001WO2001005742A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
01/25/2001WO2001005741A1 Method for producing amines by homogeneously catalyzed reductive amination of carbonyl compounds
01/25/2001WO2000066587A3 Polyamines and their use in therapy
01/25/2001DE19934433A1 New N-(indolyl-carbonyl)-N'-ethyl-piperazine derivatives, are 5-HT-2A receptor antagonists useful e.g. for treating schizophrenia, depression, Parkinson's disease, Alzheimer's disease or anorexia
01/25/2001DE19934394A1 New N-phenylnaphthalenesulfonamide derivatives useful for treatment and prevention of viral infection, especially cytomegalovirus
01/25/2001DE19934321A1 New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections
01/25/2001CA2379891A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
01/24/2001EP1070070A1 Method for producing grignard compounds
01/24/2001EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
01/24/2001EP1070046A1 Propanolamine derivatives
01/24/2001EP0610377B1 Tri-substituted tetrahydrofuran antifungals
01/24/2001CN1281451A Benzamine derivatives
01/24/2001CN1281444A Azulene hydroxamic acid derivatives as metalloprotein inhibitors
01/24/2001CN1281438A Piperazine compounds and medical use thereof
01/24/2001CN1281431A Urethanes, thio and dithio analogues, salts thereof, medicaments containing said compounds, use and method for production thereof
01/24/2001CN1281430A N-alkanoylphenylalanine derivatives
01/24/2001CN1281429A Novel aryloxy-alkyl-dialkylamines
01/24/2001CN1281335A Treatment of schizophrenia with ampakines and neuroleptics
01/23/2001US6177528 Addition polymerization catalysts
01/23/2001US6177464 Bactericides
01/23/2001US6177459 Substituted heterocyclic compounds and their use as fungicides
01/23/2001CA2191790C Biaromatic compounds containing an adamantyl group in para position; pharmaceutical and cosmetic compositions containing them and use thereof
01/23/2001CA2128202C Alkyl derivatives of trazodone with cns activity
01/18/2001WO2001004248A1 Process for producing particles of amine reaction product
01/18/2001WO2001004115A2 Novel process for synthesis of heteroaryl-substituted urea compounds